A new generic abortion pill hits the market, IVF access expands, and home births surge—each framed as progress, each carrying hidden costs. We pull apart the headlines and ask the harder question: what protects vulnerable lives when policy moves faster than moral clarity? First, we unpack the FDA’s approval of another mifepristone generic and why “identical formulation” doesn’t settle the ethical debate. Safety talk often skims maternal side effects while ignoring the unborn child’s near‑cer...
All content for The Life Challenges Podcast is the property of Christian Life Resources and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A new generic abortion pill hits the market, IVF access expands, and home births surge—each framed as progress, each carrying hidden costs. We pull apart the headlines and ask the harder question: what protects vulnerable lives when policy moves faster than moral clarity? First, we unpack the FDA’s approval of another mifepristone generic and why “identical formulation” doesn’t settle the ethical debate. Safety talk often skims maternal side effects while ignoring the unborn child’s near‑cer...
What's Trending? Oldest Embryo to Result in a Live Birth, James Dobson, Mark Surrogacy, and Endorsing Candidates from the Pulpit
The Life Challenges Podcast
33 minutes
2 months ago
What's Trending? Oldest Embryo to Result in a Live Birth, James Dobson, Mark Surrogacy, and Endorsing Candidates from the Pulpit
This episode examines recent events through a Christian perspective. • Discussion of the Minnesota church shooting, warning against using tragedy to vilify entire groups • The "world's oldest IVF baby" - embryo adoption giving life to a 30-year frozen embryo • Remembering James Dobson's significant impact on pro-life and family values movements • Examination of the Mark Surrogacy case reveals exploitation in unregulated reproductive technology • Analysis of church-state separation after a Lu...
The Life Challenges Podcast
A new generic abortion pill hits the market, IVF access expands, and home births surge—each framed as progress, each carrying hidden costs. We pull apart the headlines and ask the harder question: what protects vulnerable lives when policy moves faster than moral clarity? First, we unpack the FDA’s approval of another mifepristone generic and why “identical formulation” doesn’t settle the ethical debate. Safety talk often skims maternal side effects while ignoring the unborn child’s near‑cer...
